O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Katherine Warren, MD
National Cancer Institute (NCI)
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Children'S Memorial Hospital - Chicago
Chicago, Illinois, United States
- Dana-Farber/harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Dan L. Duncan Cancer Center at Baylor College of Medicine
Houston, Texas, United States
- Texas Children'S Cancer Center and Hematology Service at Texas Children'S Hospital
Houston, Texas, United States
- Children'S Hospital and Regional Medical Center - Seattle
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2006
- Primary completion
- 1 Dec 2010
- Completion
- 31 Dec 2010
- Last update posted
- 11 Feb 2022
- Registered enrollment
- 41
- Registry id
- NCT00275002
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.